Diabetes Champion Course #16

April 7, 2020 to April 10, 2020

Program Description

The Diabetes Champion Course provides training for primary care teams (provider & support staff) to assess and improve the diabetes care provided at their respective MTF.  Focus is on increasing individual knowledge, assessing clinical processes, facilitating team dynamics, and developing and implementing quality improvement initiatives. 

Target Audience

This activity provides continuing education for physicians, nurses, physician assistants, pharmacists, and pharmacy technicians. A certificate of attendance is available for other attendees.

Learning Objectives

  1. Discuss the scope of diabetes.
  2. Distinguish strategies to optimize provider and team behavior.
  3. Identify risk factors and metabolic defects in diabetes and pre diabetes.
  4. Analyze the clinical practice guidelines from the VADOD and American Diabetes Association.
  5. Outline programs at DCOE for patient and provider educational opportunities.
  6. List diabetes services covered by TRICARE.
  7. Discuss recognition and treatment of hypoglycemia.
  8. Analyze the strategies for dosing and titrating insulin.
  9. Compare strategies for initiating insulin.
  10. Demonstrate recognition of blood glucose patterns that could influence insulin dosing.
  11. Outline implementation of a diabetes prevention and/or GLB program.
  12. Analyze the significance of tobacco cessation.
  13. Define classes oral/injectable medications, explain use to treat type 2 diabetes and assess effectiveness.
  14. Apply VA/DOD sequential approach plan medical management of diabetes.
  15. Recognize elements in clinical case study to construct treatment plan.
  16. Identify techniques of pen injector devices and glucagon instruction.
  17. Develop an action plan.
  18. Explain the importance of preconception counseling for women with diabetes of childbearing age.
  19. Recognize the diabetes/hypertensive/ cholesterol medications contraindicated during pregnancy.
  20. Analyze the healthcare team workflow, roles and actions in the management of a PWD.
  21. Distinguish the goals of nutrition therapy for PWD.
  22. List strategies to facilitate behavior change to increase activity level.
  23. Outline strategies for providing Diabetes Self-Management Education and Support (DSMES) to PWD.
  24. Describe Motivational Interviewing (MI) and its relation to Shared Decision Making (SDM).
  25. Examine changes in medication regimens for known surgical or diagnostic procedures.
  26. Evaluate a pediatric patient with overweight/obesity for secondary causes and co morbidities.
  27. Develop strategies for initiation of insulin therapy.
Course summary
Available credit: 
  • 23.00 AAPA
    DHA J-7 CEPO has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 23.00 hours of AAPA Category 1 CME credits. Physician assistants should only claim credit commensurate with the extent of their participation.
  • 23.00 ACPE Pharmacist
    UAN JA4008136-0000-20-056-L04-P
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 23.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 23.00 ACPE Pharmacy technician
    UAN JA4008136-0000-20-056-L04-T
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 23.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 23.00 AMA PRA Category 1 Credit™
    DHA J-7 CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. DHA J-7 CEPO designated this Internet Live Course activity for a maximum of 23.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 23.00 ANCC
    DHA J-7 CEPO is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. DHA J-7 CEPO designated this Internet Live Course activity. Continuing Nursing Education activity for a maximum of 23.00 contact hours Nurses should only claim credit commensurate with the extent of their participation in the activity.
  • 23.00 Certificate of Attendance
Course opens: 
02/11/2020
Course expires: 
04/26/2020
Event starts: 
04/07/2020 - 08:00
Event ends: 
04/10/2020 - 00:40

 

 

CONTINUING HEALTH EDUCATION OUTLINE DCC #16 (April 7-10, 2020)

LEARNING OBJECTIVES

(State in operational/behavioral terms)

CONTENT

(Relate to objectives; list each topic area and outline of the content to be presented)

TEACHING

MINUTES/ CONTACT

HOURS

 

FACULTY

 PRESENTER

(List presenter for each topic area)/

TEACHING METHODS/INSTRUCTIONAL

MEDIA/EVALUATION PLAN

(Describe teaching method(s) for each topic area. Attach copy of tests, performance checklist, offering critique, etc.)

0800-0815 Welcome

Discuss course requirements, methods of instruction, expectations of student/instructor performance and conduct, outcomes measures and CE credit hours awarded

Welcome

CE Disclosure statement

Orientation to base and WHASC

Course requirements

Course materials and CE hours awarded

Measures of outcomes (pre-assessment, 30-day survey, 8-month post-assessment, practical application)

Introduce CPG/QI Implementation Activity

 

0 min

 

Connie Morrow, MAEd-AET, DCOE Outreach

 

 Lecture/PowerPoint slides

0815-0945 Scope of Diabetes, Role of Champion

 

  1. Discuss the scope of diabetes

 

  1. Define/describe role of Diabetes Champion

 

  1. Outline strategies to facilitate change in the care system

 

  1. Summarize benefits of having a champion and CPG team

 

  1. Distinguish strategies to optimize provider and team behavior

 

  1. Compare strategies to support patient behavior change

 

  1. Introduce CPG/QI project requirement for course participation (part 1)

 

  1. Analyze findings of previous courses

 

Incidence Direct costs Indirect costs Quality of life

Challenges in AFMS

Role and duties of Diabetes Champion Implementation strategies

  • Secure executive buy-in
  • Develop/implement action plan

-team identification

-data collection

  • Facilitate Change

-identify barriers

-provide training

  • Monitor progress

-identify metrics

Delineating Staff roles / responsibilities Implementing a system for planned visits for diabetes care

Supporting the use of evidence-based guidelines Identify resources

Using the patient registry (CarePoint)

Incorporating diabetes management self-education and support into every visit

Expectations for course clinical practice guideline/quality improvement (CPG/QI) project

Previous course and participant examples

Previous participant findings: Identifying barriers and finding solutions.

 

 

 

 

 

 

 

 

 

 

90 min

 

 

 

 

 

 

 

 

 

 

Maj Darrick Beckman, MD

 

 

 

 

 

 

 

 

 

 

Lecture/PowerPoint slides Handouts

1000-1130 Current Evidence-Based Practice Guidelines in Diabetes

  1. Identify risk factors and metabolic defects in diabetes

Normal glucose metabolism Pre-diabetes: IGF, IGT Diabetes: Type 1, Type 2, other Glycemic goals in diabetes

Diagnosis of diabetes and pre-diabetes

 

 

90 min

 

 

 Dr. Tom Sauerwein

 

Lecture/PowerPoint slides/Student

  Handouts

 

and pre-diabetes

  1. Describe principles of evidenced- based practice
  2. Summarize the clinical practice guidelines from the VADOD and American Diabetes Association
  3. Discuss treatment recommendations for diabetes

Sources of evidence-based practice to guide clinical practice of diabetes management

  VADOD Diabetes Clinical Practice Guideline

American Diabetes Association 2019 Medical Standards of Care

Treatment goals for HTN and HLP

Treatment algorithms

 

 

 

 

 

 

1230-1315 Professional and Community Resources for Diabetes Management

  1. Identify diabetes services covered by TRICARE
  2. Summarize resources to provide support to the multidisciplinary team
  3. Outline programs at DCOE for patient and provider educational opportunities

Diabetes Services available through TRICARE Professional Resources

  • CDC
  • AMEDD
  • CEMM Programs
  • Diabetes Central
  • Project ECHO (Diabetes and Prevention)
  • DCS Webinars

 

 

45 min

 

 

Karen Rader, RN

 

Lecture/PowerPoint slides Demonstration of Diabetes Central

Demonstration of Center of Excellence for Medical Multimedia

Handouts

1330-1400 Overview of Acute Complications of Diabetes

  1. Discuss recognition and   treatment of hypoglycemia
  2. Outline strategies for sick day management
  3. Summarize recognition  and treatment of life-threatening acute complications

Acute complications of diabetes

  • Hypoglycemia
  • Hyperglycemia (DKA)
  • Concurrent illness (sick days)

 

 

30 min

 

 

 Maj Craig Jenkins, MD

 

 

Handouts

Case Studies (Interactive Participation)

Lecture/PowerPoint slides

1415-1515 Pharmacotherapy: Insulin Therapy

 

  1. Outline the role of insulin in treating/managing PWD
  2. Compare the types of insulin available
  3. Analyze the strategies for dosing and titrating insulin

Types of insulin and insulin analogs

  • Onset, duration, precautions, pt education
  • Insulin devices
  • Pens

Pumps Dosing/titrating insulin Pattern management

 

 

 

 

60 min

 

 

 

 

 

 

 

 

 

 

 LTC Sky Graybill, MD

 

Lecture/PowerPoint slides Titration worksheets

 

 

 

 

 

 

 

 

                                                      

1530-1630 Pharmacotherapy: Insulin Therapy (part 2)

  1. Compare strategies for initiating insulin
  2. Outline titration/dosing of insulin
  3. Demonstrate recognition of blood glucose patterns that could influence insulin dosing

 

Presentation of case studies.

  • When to initiate insulin
  • Recognition of blood glucose patterns
  • Strategies to titrate insulin

Patient self-titration

Case study 1 (Insoljin)

  • Assessment of health status
  • Medication considerations

Psychosocial considerations

 

 

60 min

  

 

 LTC Sky Graybill, MD

   Nina Watson, RN

 

Lecture/PowerPoint slides

Case Studies (Interactive Participation)

Group Discussion

 

DAY TWO

 

 

 

 

0800-0915 Pre-diabetes and Diabetes Prevention

  1. Discuss the research supporting primary diabetes prevention.
  2. Summarize CDC and GLB prevention programs
  3. Outline implementation of a diabetes prevention and/or GLB program

Review of diabetes prevention research

  • DPP
  • DPPOS
  • GLB/DPSC

 

Discuss available prevention programs Facilitator Training

  • Recommendations for MTF implementation

 

 

75 min

 

 

 

 

 

Maj Maria Kravchenko, MD

 

  Lorena Urbina, CPT/CES

 

 

 

 

 

Lecture/PowerPoint slides

Handouts

DVD/CD 2 demonstration Interactive Participation

 

 

 

0930-1030 Overview of Complications: Chronic

  1. Summarize the prevention, recognition, and treatment of cardiovascular complications of diabetes
  2. Outline the prevention, recognition, and treatment of microvascular complications of diabetes
  3. Analyze the significance of tobacco cessation

Chronic complications of diabetes

  • Microvascular
  • Macrovascular

Preventative screening

Smoking Cessation Immunizations

 

 

60 min

 

 

Capt Jennifer Wan, MD

 

Lecture/PowerPoint slides Handouts

Case Studies (Interactive Participation)

1045-1200

Pharmacotherapy: Non-Insulin Medications

  1. Define classes oral/injectable medications, explain use to treat type 2 diabetes and assess effectiveness
  2. State factors to consider when prescribing medications to treat diabetes and determine proper management
  3. Apply VA/DOD sequential approach plan medical management of diabetes
  4. Recognize elements in clinical case study to construct treatment plan

Reasons for monitoring Continuous glucose monitoring Interpreting the numbers

 

Classifications of diabetes medications

  • Purpose, action, dosing, side effects, precautions, patient education
  • Oral: Biguanides, sulfonylureas, TZDs, Alpha-glucosidase inhibitors, glinides, DPP-4 inhibitors, SGLT2 inhibitors, bile acid sequestrants
  • Injectable: incretin mimetics, amylin analogs

  Management of medication regimens

Pattern management

 

 

 

 

 

    75 min

 

 

 

Maj Philip Clerc, MD

 

 

 

 

 

 

 

 

Lecture/PowerPoint slides Handouts

Case Studies (Interactive Participation)

1300-1530 Skills for Diabetes Management:

  1. Validate assessment skill for a comprehensive foot exam
  2. Demonstrate techniques and data download for glucose monitoring devices
  3. Identify techniques of pen injector devices and glucagon instruction
  4. Show the function of insulin pumps and continuous glucose monitoring devices

 

 

Part 1: Comprehensive foot exam

 

Part 2: Glucose monitoring devices (patient use and downloading)

 

Part 3: Pen injector device & Glucagon teaching Strategies

 

  Part 4: Insulin pumps & Continuous Glucose 

               Monitoring Systems

 

 

    150 min

 

 

Donald Cobb, LVN

Dave Beavers, RN

Karen Rader, RN

Adamaris Rivera- Santiago, PharmD

Ellen Kilpatrick-Cobb, RN

Jana Wardian, PhD

 

Group Demonstration/Return demonstration Handouts

1530-1630

CPG / QI:  Discuss & Develop (part 2)

  1. Discuss identified gaps in practice
  2. Develop an action plan
  3. Apply strategies to implement action plan

Practical application of:

  • Implementation strategies
  • Identify Diabetes Team

Develop strategies to implement action plan

 

 

   60 min

 

 

Nina Watson, RN

Connie Morrow, MAEd

Small Group Activity/Discussion

 

 

DAY THREE

 

 

 

 

0800-0915 Reproductive Health in Women with Diabetes

  1. Explain the importance of preconception counseling for women with diabetes of childbearing age
  2. Summarize the importance of glucose management before, during, and after pregnancy
  3. Identify the diabetes/hypertensive/ cholesterol medications contraindicated during pregnancy
  4. Discuss follow-up of women with gestational diabetes post pregnancy

Preconception Care/Counseling

Implications of poor glucose control on pregnancy

Medications contraindicated during pregnancy

Post-partum considerations

Gestational Diabetes

 

 

75 min

 

 

Lt Col Larissa Weir, MD

 

Lecture/PowerPoint slides

  Case Studies (Interactive Participation)

0930-1030 Case Studies 1-2

  1. Analyze the healthcare team workflow, roles and actions in the management of a PWD
  2. Discuss strategies for initiation of insulin therapy
  3. Summarize implication of a diagnosis of diabetes for the active duty patient
  4. Review Military Evaluation Board (MEB) process

Case study 1 (Babbe)

  • Assessment of health status
  • Medication considerations
  • Psychosocial considerations
  • Preconception Counseling
  • Medical Evaluation Board process

Case study 2 (Pennerknie)

  • Assessment of health status
  • Medication considerations
  • Psychosocial considerations
  • Medical Evaluation Board process

 

 

60 min

 

 

Darrick Beckman, MD

 

 

 

PowerPoint slides

Group Participation Case Study

1030-1045 CPG / QI:  Q & A (Part 3)

  1. Describe MTF action plan
  2. Identify gaps in practice
  3. Explain strategies to implement action plan

  Question and Answer session

 

 

 

15 min

 

 

Karen Rader, RN

 

 

Participant presentations. Group Discussion

1100-1215 Lifestyle Management (1): Nutritional Guidelines

  1. Review current recommendations for medical nutritional therapy (MNT) for people with diabetes (PWD)
  2. Distinguish the goals of nutrition therapy for PWD
  3. Compare strategies to facilitate healthy eating behaviors

CPG recommendations for MNT (VA/DoD, ADA, AND)

Healthy eating instruction

Meal planning strategies: Carb Counting, Food Guide Pyramid, Plate Method, Glycemic Index

 

 

75 min

 

 

Denise Sprague, RD

 

Lecture/PowerPoint slides Handouts

Carb calculation practice

1315-1400 Lifestyle Management (2): Physical Activity

  1. Summarize exercise/physical activity recommendations for PWD
  2. List strategies to facilitate behavior change to increase activity level
  3. Identify ways to reduce risk of hypoglycemia during exercise

 

Expected benefits: weight, lipids, glucose control, BP in Type 1, Type 2 and pre-diabetes

Frequency and type of exercise Exercise and Glycemic control

  Presence of non-optimal glycemic control

 

 

 

45 min

 

 

 Lorena Urbina, CPT/CES

 

Lecture/PowerPoint slides

Handouts

1415-1500 Lifestyle Management (3): Diabetes Self-Management Education and Support

  1. Review current CPG (VA/DoD, ADA) recommendations for lifestyle management
  2. Outline strategies for providing Diabetes Self-Management Education and Support (DSMES) to PWD

Review of research supporting diabetes education

Define level of diabetes education providers

Current standards of care/CPG recommendations.

  • Group vs individual
  • Defining “support”

  Process for recognition and reimbursement.

 

 

 

45 min

 

 

 Ellen Kilpatrick-Cobb, RN

 

Lecture/PowerPoint slides

Handouts

1515-1630 Lifestyle Management (4):  Psychosocial Assessment and Care

  1. Identify challenges to outstanding clinical outcomes
  2. Describe Motivational Interviewing (MI) and its relation to Shared Decision Making (SDM)
  3. Discuss role of the Internal Behavioral Health Consultant (IBHC)
  4. Review brief psychosocial outcome measures options

Review of psychological and social problems associated with diabetes

Identifying depression

Use of BHOP in the PCMH

 

Barriers to self-care

Review of Motivational Interviewing techniques. Presentation of scenarios/case studies to facilitate discussion.

  Guided practice session for participants.

 

 

 

    75 min

 

 

Ann Hryshko- Mullen, PhD

Capt Blue Star, PhD

Maj Marc Patience, PhD

 

 

Slides

Group Participation Case Study

 

 

DAY FOUR

 

 

 

 

0800-0900 Managing Pre/Post Hospitalization

  1. Outline considerations for PWD when scheduling elective surgeries
  2. Summarize changes in medication regimens for known surgical or diagnostic procedures
  3. Compare strategies for follow-up post hospitalization

Pre-operative evaluation (suitability)

Medication management changes in peri-operative care

  • Orals
  • Insulin

Re-establishing the “home” regimen of medical care

 

 

60 min

 

 

Maj Jeffrey Colburn, MD

 

 

Lecture/PowerPoint slides

0915-1030 Managing the

Managing the pediatric diabetes patient

 

 

 

  Pediatric Diabetes Patient

Childhood obesity

75 min

Lt Col John

Lecture/PowerPoint slides

  1. Describe the obesity epidemic in the US and the world
  2. Define obesity in children and how to make the diagnosis
  3. Evaluate a pediatric patient with overweight/obesity for secondary causes and co morbidities
  4. Discuss and apply techniques utilizing motivational interviewing in the encounter with an overweight/obese patient
  5. Summarize the Primary Care role in the management of the pediatric diabetes patient

Rates of childhood obesity

Cycle of childhood obesity

Importance

Barriers to discussing and treating obesity

Healthy Habits Clinic

Readiness to Change

Motivation Interviewing

Goal Setting

ADA Criteria for T1DM and T2 DM

Special considerations for pediatric patients

Federal and State laws and regulations on equal Access

Management of pediatric sick days

BG Management Goals

 

Oberlin, MD  

Lt Col Candace Percival, MD

 

 

 

 

 

 

 

 

 

1040-1110 Case Study 3

  1. Analyze the healthcare team workflow, roles and actions in the management of a PWD
  2. Develop strategies for initiation of insulin therapy

Case study 3 (Foote)

  • Assessment of health status
  • Medication considerations
    1. Regimen
    2. hypoglycemia
  • Psychosocial considerations

 

 

30 min

 

 

Maj Craig Jenkins, MD

 

 

Group Participation Case Study

1110-1140 CPG/QI: Presentations (part 4)

  1. Describe MTF action plan.
  2. Identify gaps in practice
  3. Explain strategies to implement action plan

Practical application of:

  • Implementation strategies
  • Identify Diabetes Team

 Present strategies to implement action plan

 

 

30 min

 

 

 Karen Rader, RN

 

Participant presentations

  Group Discussion

1200-1300 Participate in ECHO™ Conference

 

ECHO™ conference: Diabetes and Obesity

 

0 min

 

  Connie Morrow, MAEd

Lecture/PowerPoint slides via Video Tele-conference

Case study

1300-1330

Program Feedback/Surveys

  • Collect evaluations
  • Question and Answer

Distribute certificates/Dismissal

 

0 min

 

Outreach Team

 

Interactive

Total CE hours:  23.0

San Antonio, TX
United States
  • Maj Darrick Beckman, MD. Presenter has no financial or non-financial relationships to disclose.
  • Tom Sauerwein, MD. Presenter has no financial or non-financial relationships to disclose.
  • Karen Rader, RN. Presenter has no financial or non-financial relationships to disclose.
  • Maj Craig Jenkins, MD. Presenter has no financial or non-financial relationships to disclose.
  • LTC Sky Graybill, MD. Presenter has no financial or non-financial relationships to disclose.
  • Nina Watson, RN. Presenter has no financial or non-financial relationships to disclose.
  • Maj Maria Kravchenko, MD. Presenter has no financial or non-financial relationships to disclose.
  • Lorena Urbina, CPT/CES. Presenter has no financial or non-financial relationships to disclose.
  • Capt Jennifer Wan, MD. Presenter has no financial or non-financial relationships to disclose.
  • Maj Philip Clerc, MD. Presenter has no financial or non-financial relationships to disclose.
  • Donald Cobb, LVN. Presenter has no financial or non-financial relationships to disclose.
  • Dave Beavers, RN. Presenter has no financial or non-financial relationships to disclose.
  • Timothy Corbin, Pharm. Presenter has no financial or non-financial relationships to disclose.
  • Adamaris Rivera- Santiago, PharmD. Presenter has no financial or non-financial relationships to disclose.
  • Ellen Kilpatrick-Cobb, RN. Presenter has no financial or non-financial relationships to disclose.
  • Jana Wardian, PhD. Presenter has no financial or non-financial relationships to disclose.
  • Connie Morrow, MAEd. Presenter has no financial or non-financial relationships to disclose.
  • Lt Col Larissa Weir, MD. Presenter has no financial or non-financial relationships to disclose.
  • Maj Alexis Beauvais, MD. Presenter has no financial or non-financial relationships to disclose.
  • Denise Sprague, RD. Presenter has no financial or non-financial relationships to disclose.
  • Ellen Kilpatrick-Cobb, RN. Presenter has no financial or non-financial relationships to disclose.
  • Ann Hryshko- Mullen, PhD. Presenter has no financial or non-financial relationships to disclose.
  • Capt Blue Star, PhD. Presenter has no financial or non-financial relationships to disclose.
  • Maj Jeffrey Colburn, MD. Presenter has no financial or non-financial relationships to disclose.
  • Lt Col John Oberlin, MD. Presenter has no financial or non-financial relationships to disclose.
  • Lt Col Candace Percival, MD. Presenter has no financial or non-financial relationships to disclose.
  • Maj Craig Jenkins, MD. Presenter has no financial or non-financial relationships to disclose.

Disclosure

DHA J-7 staff, Planning Committee Members and reviewers have no financial or non-financial interest to disclose. All faculty members have no financial or non-financial interest to disclose.

Available Credit

  • 23.00 AAPA
    DHA J-7 CEPO has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 23.00 hours of AAPA Category 1 CME credits. Physician assistants should only claim credit commensurate with the extent of their participation.
  • 23.00 ACPE Pharmacist
    UAN JA4008136-0000-20-056-L04-P
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 23.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 23.00 ACPE Pharmacy technician
    UAN JA4008136-0000-20-056-L04-T
    No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 23.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity.
  • 23.00 AMA PRA Category 1 Credit™
    DHA J-7 CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. DHA J-7 CEPO designated this Internet Live Course activity for a maximum of 23.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 23.00 ANCC
    DHA J-7 CEPO is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. DHA J-7 CEPO designated this Internet Live Course activity. Continuing Nursing Education activity for a maximum of 23.00 contact hours Nurses should only claim credit commensurate with the extent of their participation in the activity.
  • 23.00 Certificate of Attendance
Please login or register to take this course.